It is probable to employ serum S100B level in monitoring treatment for stroke.59 In stroke patients, there was a regular increase in S100B 1-3 days after the onset of symptoms followed by slowly decreasing values as already depicted by others.60 This evidence concerns the gene S100B and stroke disorder.